Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.
Eli Lilly’s new GLP-1 drug and diversified R&D pipeline could drive healthcare sector inflows and deliver over 40% upside. See here for more on LLY stock.
Eli Lilly continues to establish its dominance in the growing market for GLP-1 therapies. The company's oral candidate for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback